Correlation Between Haemonetics and Sanara Medtech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Haemonetics and Sanara Medtech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Haemonetics and Sanara Medtech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Haemonetics and Sanara Medtech, you can compare the effects of market volatilities on Haemonetics and Sanara Medtech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Haemonetics with a short position of Sanara Medtech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Haemonetics and Sanara Medtech.

Diversification Opportunities for Haemonetics and Sanara Medtech

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Haemonetics and Sanara is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Haemonetics and Sanara Medtech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sanara Medtech and Haemonetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Haemonetics are associated (or correlated) with Sanara Medtech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sanara Medtech has no effect on the direction of Haemonetics i.e., Haemonetics and Sanara Medtech go up and down completely randomly.

Pair Corralation between Haemonetics and Sanara Medtech

Considering the 90-day investment horizon Haemonetics is expected to generate 1.0 times more return on investment than Sanara Medtech. However, Haemonetics is 1.0 times more volatile than Sanara Medtech. It trades about 0.0 of its potential returns per unit of risk. Sanara Medtech is currently generating about 0.0 per unit of risk. If you would invest  7,487  in Haemonetics on October 20, 2024 and sell it today you would lose (138.00) from holding Haemonetics or give up 1.84% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Haemonetics  vs.  Sanara Medtech

 Performance 
       Timeline  
Haemonetics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Haemonetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Haemonetics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Sanara Medtech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sanara Medtech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Sanara Medtech is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Haemonetics and Sanara Medtech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Haemonetics and Sanara Medtech

The main advantage of trading using opposite Haemonetics and Sanara Medtech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Haemonetics position performs unexpectedly, Sanara Medtech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sanara Medtech will offset losses from the drop in Sanara Medtech's long position.
The idea behind Haemonetics and Sanara Medtech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Stocks Directory
Find actively traded stocks across global markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories